EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Emmeran Gams
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schipke, J. D.
Right arrow Articles by Gams, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schipke, J. D.
Right arrow Articles by Gams, E.
Related Collections
Right arrow Cardiac - other
Right arrow Extracorporeal circulation
Right arrow Myocardial protection

Eur J Cardiothorac Surg 2006;29:479-485
© 2006 Elsevier Science NL


Review

Forty years of glucose–insulin–potassium (GIK) in cardiac surgery: a review of randomized, controlled trials

Jochen D. Schipke a , * , Rainer Friebe a , Emmeran Gams b

a Research Group Experimental Surgery, Department of Thoracic- and Cardiovascular Surgery, University Hospital Duesseldorf, Moorenstr. 5, D-40225 Düsseldorf, Germany
b Department of Thoracic- and Cardiovascular Surgery, University Hospital Duesseldorf, Duesseldorf, Germany

Received 10 November 2005; received in revised form 11 January 2006; accepted 12 January 2006.

* Corresponding author. Tel.: +49 211 81 19949; fax: +49 211 81 16996. (Email: schipke{at}med.uni-duesseldorf.de).

Glucose–insulin–potassium (GIK) solutions have been used in cardiac surgery for more than 40 years. At that time, membrane-polarizing and stabilizing effects on cardiomyocyte's action potential were regarded the main benefit. Two meta-analyses described methodological flaws in the early studies (e.g., case numbers, randomization principles, and levels of significance), and came to clearly different recommendations with regard to the usage of GIK in the therapy of acute myocardial function. During the 70s, as promising therapies for the treatment of AMI had become available (e.g., ß-blockers and thrombolytic agents), the GIK technique was more widely introduced in cardiac surgery, e.g., during valve replacement. At present, 74 of 91 studies provide convincing evidence for the beneficial effects of insulin and/or GIK in cardiac surgery that go far beyond simple metabolic benefits and also include better recovery of myocardial tissue after ischemia. Yet, the exact underlying mechanisms remain still unknown. In this review article, two questions will be answered: why did GIK not become daily routine in cardiac surgery in spite of positive results from clinical studies, and does this technique merit more acceptance among the potential users? In view of the increasing number of older patients at higher risk, the demand for improving surgical procedures has renewed the interest in the GIK concept. The more recent literature suggests that the entire potential of GIK solutions has not been fully disclosed. A large single or multicenter trial with sound endpoints is mandatory.

Key Words: Cardioprotection • GIK mechanisms • Randomized trials • Endpoints




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
L. Bertrand, S. Horman, C. Beauloye, and J.-L. Vanoverschelde
Insulin signalling in the heart
Cardiovasc Res, July 15, 2008; 79(2): 238 - 248.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Albacker, G. Carvalho, T. Schricker, and K. Lachapelle
High-dose insulin therapy attenuates systemic inflammatory response in coronary artery bypass grafting patients.
Ann. Thorac. Surg., July 1, 2008; 86(1): 20 - 27.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Gandhi, B. A. Finegan, and A. S. Clanachan
Role of glucose metabolism in the recovery of postischemic LV mechanical function: effects of insulin and other metabolic modulators
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2576 - H2586.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. A. Kloner and R. W. Nesto
Glucose-Insulin-Potassium for Acute Myocardial Infarction: Continuing Controversy Over Cardioprotection
Circulation, May 13, 2008; 117(19): 2523 - 2533.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.